Table of Contents
I. Addiction Research: There's an App for that NOT-DA-15-080
II. BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01) RFA-MH-16-810
III. BRAIN Initiative: Non-Invasive Neuromodulation - Mechanisms and Dose/Response Relationships for Targeted CNS Effects (R01) (RFA-MH-16-815)
IV. BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01) RFA-NS-16-006
V. BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01) RFA-NS-16-007
VI. Funding opportunities issued for the NIH Precision Medicine Initiative® Cohort Program NOT-PM-16-001
I. Addiction Research: There's an App for that NOT-DA-15-080
Deadline for Submission: April 29, 2016
Monetary prizes may be awarded: $50,000 1st place, $30,000 2nd place, $20,000 3rd place
Funding Opportunity Purpose
The National Institute on Drug Abuse (NIDA) announces a new Challenge/Prize Competition, "Addiction Research: There's an App for that" (https://www.federalregister.gov/articles/2015/11/03/2015-27939/national-institutes-of-health-national-institute-on-drug-abuse-nida-announcement-of-requirements-and)
The objective of this Challenge is to promote the development of innovative mobile applications (apps) for future addiction studies. The Challenge requires that the apps be explicitly created using Apple Inc.’s ResearchKit™, an open-source software kit designed specifically for biomedical and health research. NIDA encourages addiction researchers to use the newly available technical capabilities of ResearchKit™ and seek collaboration(s) with app developers and engineers to create the winning research app.
Please direct all inquiries to:
Elena Koustova, PhD, MBA
National Institute on Drug Abuse (NIDA)
Telephone: 301-496-8768
Email: elena.koustova@nih.gov
II. BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01) (RFA-MH-16-810)
National Institute of Mental Health
Application Receipt Date: February 18, 2016, by 5:00 PM local time of applicant organization.
Funding Opportunity Purpose
This Funding Opportunity Announcement (FOA) solicits grant applications in two related but distinct areas. The first area is in the development and testing of novel tools and methods of neuromodulation that go beyond the existing variations on magnetic or electrical stimulation, and that represent more than an incremental advance over existing electromagnetic approaches. The second distinct area that this FOA seeks to encourage is the optimization of existing electrical and magnetic stimulation methods. Please read entire announcement for further details.
III. BRAIN Initiative: Non-Invasive Neuromodulation - Mechanisms and Dose/Response Relationships for Targeted CNS Effects (R01) (RFA-MH-16-815)
Application Due Date: February 18, 2016, by 5:00 PM local time of applicant organization
Funding Opportunity Purpose
The focus of this Funding Opportunity Announcement (FOA) is to better understand how existing non-invasive neuromodulation devices affect brain circuity. This information should shed light on dose/response relationships that could be used for neuroscience applications and clinical interventions. Please read entire announcement for details. Please read entire announcement for details.
IV. BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01) RFA-NS-16-006
Application Due Date: February 24, 2016 by 5:00 PM local time of applicant organization.
Funding Opportunity Purpose
Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for large-scale recording and manipulation of neural activity to enable transformative understanding of dynamic signaling in the nervous system. In particular, we seek exceptionally creative approaches to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful could profoundly change the course of neuroscience research.
Proposed technologies should be compatible with experiments in behaving animals, and should include advancements that enable or reduce major barriers to hypothesis-driven experiments. Technologies may engage diverse types of signaling beyond neuronal electrical activity for large-scale analysis, and may utilize any modality such as optical, electrical, magnetic, acoustic or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. Where appropriate, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis. Please read entire announcement for further details.
V. BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01)RFA-NS-16-007
Funding Opportunity Purpose
Although invention and proof-of-concept testing of new technologies is a key component of the BRAIN Initiative, to achieve their potential these technologies must also be optimized through feedback from end-users in the context of the intended experimental use. This seeks applications for the optimization of existing and emerging technologies and approaches that have potential to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and temporal scales, in any region and throughout the entire depth of the brain. This FOA is intended for the iterative refinement of emergent technologies and approaches that have already demonstrated their transformative potential through initial proof-of-concept testing, and are appropriate for accelerated development of hardware and software while scaling manufacturing techniques towards sustainable, broad dissemination and user-friendly incorporation into regular neuroscience practice.
Proposed technologies should be compatible with experiments in behaving animals, and should include advancements that enable or reduce major barriers to hypothesis-driven experiments. Technologies may engage diverse types of signaling beyond neuronal electrical activity for large-scale analysis, and may utilize any modality such as optical, electrical, magnetic, acoustic or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. Applications are expected to integrate appropriate domains of expertise, including where appropriate biological, chemical and physical sciences, engineering, computational modeling and statistical analysis. Please read entire announcement for further details.
VI. Funding opportunities issued for the NIH Precision Medicine Initiative® Cohort Program NOT-PM-16-001
Key Dates
Release Date: November 25, 2015
Related Announcements
NOT-OD-15-159 Precision Medicine Initiative Cohort Program Recommendations Issued and Accepted
RFA-PM-16-001 Precision Medicine Initiative® Cohort Program Coordinating Center (U2C)
RFA-PM-16-002 Precision Medicine Initiative® Cohort Program Healthcare Provider Organization Enrollment Centers (UG3/UH3)
RFA-PM-16-003 Precision Medicine Initiative® Cohort Program Participant Technologies Center (U24)
RFA-PM-16-004 Precision Medicine Initiative® Cohort Program Biobank (U24)
PM-OT-16-001 Precision Medicine Initiative® Cohort Program Direct Volunteers Pilot Studies
PM-OT-16-002 Communication Support for the Precision Medicine Initiative® Research Programs at NIH
Issued by
Office of Strategic Coordination (Common Fund)
Purpose
On November 17, the NIH issued the first set of funding opportunities associated with the implementation of the NIH Precision Medicine Initiative ® (PMI) Cohort Program. These included four (4) funding opportunity announcements for cooperative agreements, and two (2) funding opportunities for Other Transaction awards.
Together, the projects these funding opportunities support will build a solid infrastructure for the PMI Cohort Program. The cooperative agreements will support a coordinating center (RFA-PM-16-001), network of healthcare provider organizations (RFA-PM-16-002), participant mobile technologies (RFA-PM-16-003), and a biobank (RFA-PM-16-004). The Other Transaction awards will develop a pilot program to inform the creation of the direct volunteer enrollment component of the cohort (OT-PM-16-001), and develop a communication infrastructure that will be vital to conveying the importance of this research effort (OT-PM-16-002).
Links to all funding opportunities supporting the PMI Cohort Program may be accessed through the NIH PMI website's Funding Opportunities page: http://www.nih.gov/precision-medicine-initiative-cohort-program/funding-opportunities.
Inquiries
Please direct all inquiries to:
Irene Haas
PMI Cohort Program Agreements Officer
Email: PMICPFOAInquiries@mail.nih.gov
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contactjpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment